Table 1 Characteristics of primary and metastatic cancer patients

From: DNA methylation profiling to determine the primary sites of metastatic cancers using formalin-fixed paraffin-embedded tissues

 

Metastatic cancer (n = 215)

Primary cancer (n = 498)

Cancer types, n (%)

 Breast

26 (12)

61 (12.2)

 Cervix

9 (4.2)

46 (9.2)

 Colon and rectum

31 (14.4)

55 (11)

 Esophagus

17 (7.9)

44 (8.8)

 Stomach

29 (13.5)

48 (9.6)

 Head and neck

20 (9.3)

48 (9.6)

 Liver and bile duct

9 (4.2)

46 (9.2)

 Lung

26 (12)

57 (11.4)

 Ovary

17 (7.9)

49 (9.8)

 Thyroid

31 (14.4)

44 (8.8)

Clinical stage, n (%)

 I

2 (0.9)

95 (19.1)

 II

5 (2.3)

156 (31.3)

 III

49 (22.8)

159 (31.9)

 IV

120 (55.8)

88 (17.7)

 Unknown

39 (18.1)

0 (0)

Biopsy site, n (%)

 Lymph node

118 (54.9)

 

 Liver

25 (11.6)

 

 Abdominal cavity

11 (5.1)

 

 Lung

8 (3.7)

 

 Pelvic cavity

5 (2.3)

 

 Hydrothorax

4 (1.9)

 

 Pleura

4 (1.9)

 

 Chest wall

3 (1.4)

 

 Neck

3 (1.4)

 

 Stomach

3 (1.4)

 

 Others

30 (14.0)

 

 Unknown

1 (0.5)